Jinan Kangyue Qiming Investment Partnership (Limited Partnership) agreed to acquire 7.4% stake in Chengdu Kanghua Biological Products Co., Ltd. (SZSE:300841) from Aokang Group Co., Ltd. and Wang Zhentao for approximately CNY550 million on August 24, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
61.49 CNY | -2.10% | -2.24% | -20.70% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.70% | 1.15B | |
-2.56% | 89.69B | |
+2.50% | 41.34B | |
-12.01% | 33.72B | |
+62.74% | 26.11B | |
-19.79% | 14.63B | |
-8.58% | 12.84B | |
-12.34% | 11.66B | |
-43.92% | 11.52B | |
+4.27% | 8.92B |
- Stock Market
- Equities
- 300841 Stock
- News Chengdu Kanghua Biological Products Co., Ltd.
- Jinan Kangyue Qiming Investment Partnership (Limited Partnership) agreed to acquire 7.4% stake in Chengdu Kanghua Biological Products Co., Ltd. from Aokang Group Co., Ltd. and Wang Zhentao for approximately CNY550 million.